Simple healing recipes for cleansing your liver and blood
After the heart and lungs, the liver is perhaps your most vital organ. When it shuts down, you die. Extreme liver conditions may result in the eventual need for dangerous liver transplants. A sluggish liver can manifest a malaise of symptoms that lead to misdiagnoses...
This study provides a possible reason why genes carrying health risks have persisted in human populations. The second found evidence for multiple variants in genes related to ageing that exhibited antagonistic pleiotropic effects. They found higher risk allele frequencies with large effect sizes for late-onset diseases (relative to early-onset diseases) and an excess of variants with antagonistic effects expressed through early and late life diseases. There also exists other recent tangible evidence of antagonistic pleiotropy in specific human genes. The SPATA31 gene has been found under strong positive genomic sele...
This study aimed to investigate the effects of various perfusion temperatures on lung graft preservation during ex vivo lung perfusion (EVLP).
Hepatitis E virus (HEV) infection can cause chronic hepatitis and can lead to liver cirrhosis and liver failure in patients after solid organ transplantation. However, there is no approved therapy of HEV infection so far.
The Model for End-Stage Liver Disease (MELD) has been used to assess risk in patients awaiting liver transplant. More recently, MELD has been applied to patients with end-stage heart disease and has been demonstrated to reveal patients at high risk for mortality after heart transplantation (HTx). It is not known whether MELD score can predict severe PGD as per the new ISHLT scale.
Liver cirrhosis has been implicated in poor outcome after heart transplant. However, no distinct correlation has been known between pre-existing ascites and outcomes after heart transplantation.
Combined lung-liver transplantation (LLT) significantly increases the complexity of lung transplantation (LT) due to operative, donor, and recipient factors. The ethics of allocating dual organs to single recipients remains controversial. There is limited information on the short and long term survival of LLT recipients.
Combined heart and liver transplantation is an uncommon operation. Given the rarity of this procedure, outcomes data have been limited to case reports and several single-institution series. To better define this patient population and augment the existing data, we report our combined heart and liver transplant experience.
Cervical cancer is the most common gynecological cancer worlwide. Squamous intraepithelial lesions (SIL) are known precursors for carcinoma of uterine c èrvix and associated to infection by human papillomavirus (HPV). Several studies have shown an increased risk of malignant anogenital lesions in recipients of kidney and liver transplants compared to the general population, but there is less information in heart transplanted recipient
We present the first case series of adult patients receiving En-Bloc Heart-Liver Transplant (En-Bloc HLTx).
In patients with liver failure who have coexisting heart failure, combined heart-liver transplantation (CHLT) can be performed. Outcomes in terms of survival and freedom from rejection remain largely unknown due to lack of sufficient data. The goal of this study was to pool the existing literature for evaluating outcomes after CHLT.